Physician profile
Michael E Monaco
NPI 1942263215
$1,192.83
in general payments reported to CMS, 2019-2025
17 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.40 · 2022: $114 · 2023: $20.00 · 2024: $596 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $267.33 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Esperion Therapeutics, INC. | $203.27 | 2024-2025 | Nexletol, Nexlizet |
| Abbvie INC. | $179.93 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $78.65 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals Lp | $76.15 | 2024 | Airsupra |
| Lilly USA, LLC | $74.31 | 2024-2025 | Mounjaro, Zepbound |
| Amgen INC. | $49.11 | 2024-2025 | Evenity, Prolia |
| Antares Pharma, INC. | $46.15 | 2024-2025 | Xyosted |
| Tolmar, INC. | $36.41 | 2025 | Jatenzo |
| Radius Health, INC. | $28.28 | 2024 | Tymlos |
| Abbott Laboratories | $27.28 | 2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $27.19 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $22.59 | 2024 | Trelegy Ellipta |
| Grifols USA, LLC | $20.00 | 2023 | Xembify |
| Electromed, INC. | $19.49 | 2025 | Smartvest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.40 | 2019 | |
| Exact Sciences Corporation | $18.29 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Monaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.